Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1871 of 5804
-
New ultrasound tech could change how we see kidney failure
Diagnosis CompletedThe aim of this study is to evaluate the utility of URM technology in imaging renal microcirculatory blood flow in patients with renal failure, and to investigate its clinical feasibility for assessing renal function, disease staging and monitoring treatment response.
Phase: NA • Sponsor: Ma Zhe • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
Tiny cameras may spare newborns breathing tubes during diagnosis
Disease control Recruiting nowThe investigators aim to compare rigid tracheoscopy versus flexible tracheo-video-endoscopy in neonates requiring diagnostic assessment before undergoing a congenital tracheoesophageal fistula repair.
Sponsor: Papa Giovanni XXIII Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Smart home tech could spot early dementia signs
Knowledge-focused OngoingNeuropsychiatric symptoms (NPS) refer to a range of mental and emotional issues that can be observed through how patients move, perform daily tasks, and express feelings on their faces. In this study, the investigators want to find ways to accurately and unobtrusively track these…
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Brain-Guided therapy shows promise for Late-Life depression
Symptom relief OngoingAn open-label, single-arm, clinical research study about how to make transcranial magnetic stimulation (TMS), an FDA-approved treatment, more effective for patients with late-life depression using fMRI.
Phase: NA • Sponsor: University of New Mexico • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Breath test may guide ICU nutrition, boost survival
Disease control Recruiting nowIntroduction and assumptions of the research project: Patients treated in intensive care units (ICUs) require comprehensive treatment. Nutrition is an important and integral part of this therapy. Both insufficient and excessive calorie intake are associated with poorer prognosis…
Phase: NA • Sponsor: Poznan University of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Scientists hunt for clues to catch ALS before symptoms start
Knowledge-focused Recruiting nowAlthough several molecules have been proposed as biomarker candidates, a clinically established signature for an early or even premotor diagnosis of ALS is not available. Due to the already advanced, disease stage at the time of diagnosis as well as rapid disease progression, an …
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Hope for rare disease: new drug shows promise in Long-Term study
Disease control ENROLLING_BY_INVITATIONThe goal of this clinical trial is to provide continued access to GLM101 to treat PMM2-CDG in people who have previously received GLM101 in other trials and learn about the long term effect of GLM101. Participants will complete weekly infusions of GLM101 at the same dose level re…
Phase: PHASE2 • Sponsor: Glycomine, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New mRNA vaccine targets RSV in first human trial
⭐️ VACCINE ⭐️ OngoingThe purpose of this study is to assess the reactogenicity, safety and immune response of various formulations of the RSV mRNA investigational vaccine administered in healthy participants 18-45 years of age.
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 15:03 UTC
-
New drug cocktail aims to tackle Hard-to-Treat cancers
Disease control Recruiting nowThe goal of this study is to assess the safety, tolerability, clinical activity and pharmacokinetics of Risvutatug rezetecan (Ris-Rez), also known as GSK5764227. The study will also see how the levels of Ris-Rez will change over time at different dose amounts when administered al…
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New asthma drug tested for Long-Term safety
Disease control ENROLLING_BY_INVITATIONThis is a phase 2, open-label extension study to evaluate the long-term safety and efficacy of lunsekimig in adult participants with asthma who have previously completed the parent studies. After completion of the parent study, eligible participants will be offered the opportunit…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Hope for hepatitis delta patients: study seeks to end lifelong treatment
Knowledge-focused OngoingFinding biomarkers for stopping bulevirtide treatment of patients with hepatitis delta
Phase: NA • Sponsor: Hannover Medical School • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Hope for rare eye infection: polihexanide shows promise in small study
Disease control CompletedThis will be a non-interventional study with secondary use of data. The study will be a site-based retrospective review of medical chart of patients with AK who initiated and completed a treatment with 0.8 mg/ml polihexanide as part of a compassionate use program. Patientlevel da…
Sponsor: SIFI SpA • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Blood test may predict cancer recurrence in head and neck patients
Knowledge-focused Recruiting nowSquamous cell carcinomas of the upper aero-digestive tract (SCC-UADT) represent the seventh cause of cancer and affect approximately 600,000 patients per year worldwide. The majority of UADT cancers are diagnosed at an advanced stage (70.3% at stage III and IV) and less than 60% …
Phase: NA • Sponsor: Institut de Cancérologie de Lorraine • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Madagascar study tests whether sex ed can curb school violence
Knowledge-focused ENROLLING_BY_INVITATIONThe study will evaluate a comprehensive sexual education program (CSE) delivered by Projet Jeune Leader (PJL), a women-led non-governmental program in Madagascar. The study will randomize 50 rural middle schools (grades 6-9), to either intervention (n=25) and control (n=25) schoo…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
New hip implant aims to improve joint replacement outcomes
Disease control OngoingA Multi-Center Study in Patients Undergoing Total Hip Arthroplasty with the Smith+Nephew CATALYSTEM™ Primary Hip System. The purpose of the study is to assess safety and performance of the CATALYSTEM™ and to support product approval in global markets.
Sponsor: Smith & Nephew, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New daily shot could curb appetite in obesity
Disease control CompletedThe primary objective of this study is to assess the efficacy of ROSE-010 on food intake in female subjects with overweight and obesity. The secondary objectives of this study are the following: * To assess the efficacy of ROSE-010 on hunger; * To assess the efficacy of ROSE-01…
Phase: PHASE2 • Sponsor: Rose Pharma Inc • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Talking therapy may ease symptoms of functional movement disorder
Symptom relief Recruiting nowThe goal of this pilot randomized clinical trial is to learn if Neurobehavioral Therapy (NBT) works to treat motor functional neurological disorder (mFND) (also referred to as functional motor disorder). The main questions it aims to answer are: * Does NBT lower mFND symptoms? …
Phase: NA • Sponsor: Rhode Island Hospital • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Blood test may predict brain tumor return
Knowledge-focused Recruiting nowMeningiomas are the most common primary intracranial tumors. Current treatment relies on surgical resection and radiotherapy, but molecular predictors for recurrence are lacking. This study aims to investigate epigenetic features, specifically histone post-translational modificat…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
New mRNA vaccine aims to shield older adults from RSV
⭐️ VACCINE ⭐️ OngoingThe goal of this clinical trial is to assess the safety, reactogenicity and immunogenicity of an mRNA-based vaccine, JCXH-108, the prevention of Respiratory Syncytial Virus (RSV) infection and diseases. Participants will be randomized to receive either JCXH-108 or placebo.
Phase: PHASE1 • Sponsor: Immorna Biotherapeutics, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:23 UTC
-
New pill HRS-7535 aims to tame type 2 diabetes
Disease control CompletedThe aim of this trial is to evaluate the efficacy and safety of HRS-7535 compared with placebo in subjects with type 2 diabetes mellitus with inadequate glycemic control with diet and exercise
Phase: PHASE3 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC